Literature DB >> 14615741

Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura.

Ruth Gershoni-Baruch1, Yiftah Broza, Riva Brik.   

Abstract

OBJECTIVES: Based on the fact that Henoch-Schönlein purpura (HSP) occurs in approximately 5% of persons with familial Mediterranean fever (FMF), we assessed the prevalence and significance of FMF gene mutations in children with one or more episodes of HSP. STUDY
DESIGN: Thirty-four boys and 18 girls treated for HSP at Rambam Medical Center were interviewed and asked to donate blood. Mean age at disease onset was 6.7+/-2. 4 years, and mean follow-up was 3.8+/-1.3 years. Six predominant mutations (M694V, M680I, M694I, V726A, K695R, E148Q) in the MEFV gene were studied.
RESULTS: Nine heterozygotes, three homozygotes and two compound heterozygotes, were identified. Altogether, five persons (10%) carried two mutated MEFV alleles, a number significantly exceeding that determined for the general Israeli population (1%-2%). Of these, three displayed genotypes associated with a mild form of disease (M694V/E148Q and V726A/V726A), and two had genotypes normally observed in disease-free persons (E148Q/K695R and E148Q/E148Q).
CONCLUSIONS: Occult FMF cases much more numerous than expected were identified among children presenting with HSP. Such children should be closely monitored for renal complications, and treatment with colchicine should be considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14615741     DOI: 10.1067/S0022-3476(03)00502-X

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  52 in total

1.  Partial response to anakinra in life-threatening Henoch-Schönlein purpura: case report.

Authors:  Erynn M Boyer; Martin Turman; Kathleen M O'Neil
Journal:  Pediatr Rheumatol Online J       Date:  2011-08-11       Impact factor: 3.054

2.  Mediterranean fever (MEFV) gene mutation frequency is not increased in adults with rheumatic heart disease.

Authors:  Ismail Simsek; Cem Koz; Nurcan Basar; Ismail Sari; Hakan Erdem; Salih Pay; Bunyamin Kisacik; Muhterem Bahce; Ayhan Dinc
Journal:  Clin Rheumatol       Date:  2010-07-20       Impact factor: 2.980

3.  Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever.

Authors:  D O Tchernitchko; M Gérard-Blanluet; M Legendre; C Cazeneuve; G Grateau; S Amselem
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

Review 4.  Gastrointestinal manifestations of Henoch-Schonlein Purpura.

Authors:  Ellen C Ebert
Journal:  Dig Dis Sci       Date:  2008-03-20       Impact factor: 3.199

Review 5.  Atypical clinical course of Henoch-Schonlein purpura.

Authors:  David Lawee
Journal:  Can Fam Physician       Date:  2008-08       Impact factor: 3.275

6.  Establishing hospital admission criteria of pediatric Henoch-Schonlein purpura.

Authors:  Kamal Masarweh; Yoseph Horovitz; Avi Avital; Ronen Spiegel
Journal:  Rheumatol Int       Date:  2014-02-23       Impact factor: 2.631

Review 7.  The genetics of Henoch-Schönlein purpura: a systematic review and meta-analysis.

Authors:  Xuelian He; Chunhua Yu; Peiwei Zhao; Yan Ding; Xiaohui Liang; Yulan Zhao; Xin Yue; Yanxiang Wu; Wei Yin
Journal:  Rheumatol Int       Date:  2013-01-17       Impact factor: 2.631

Review 8.  Non-canonical manifestations of familial Mediterranean fever: a changing paradigm.

Authors:  Donato Rigante; Giuseppe Lopalco; Giusyda Tarantino; Adele Compagnone; Michele Fastiggi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-03-13       Impact factor: 2.980

9.  Is there an association between familial Mediterranean fever and celiac disease?

Authors:  Zarife Kuloğlu; Z Birsin Ozçakar; Ceyda Kirsaçlioğlu; Selçuk Yüksel; Aydan Kansu; Nurten Girgin; Mesiha Ekim; Fatoş Yalçinkaya
Journal:  Clin Rheumatol       Date:  2008-03-20       Impact factor: 2.980

Review 10.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.